Skip to main content

Overview


I am a hematology/oncology fellow and post-doctoral fellow in the National Clinician Scholars Program at Duke University School of Medicine. I envision a career as an oncologist, health services/outcomes, and equity researcher focused on addressing disparities in care for patients with hematologic malignancies from under-represented backgrounds. I am interested in understanding how epidemiology, patterns, quality, and cost of care impact healthcare delivery and outcomes in patients with hematologic malignancies from under-represented backgrounds, with particular attention to factors along the continuum of care, to ultimately guide the development of appropriate interventions to address inequities.

Current Duke Appointments & Affiliations


Recent News Items


Published February 19, 2024
Fellow Dr. Allison Taylor: Improving Access of Care for Under-represented Patients with Hematologic Diseases
Published May 23, 2023
2023 Resident Research Day Features Califf Research Award Winners

View All News Items

Recent Scholarly Works


Real-World Outcomes in First-Line Venetoclax-Based Therapy in Patients With AML Ineligible for Intensive Chemotherapy: A Single Center Study.

Journal article Clin Lymphoma Myeloma Leuk · October 2026 BACKGROUND: VIALE-A established azacitidine and venetoclax as first-line therapy for patients with acute myeloid leukemia (AML) ineligible for intensive chemotherapy. However, real-world use of venetoclax often differs from clinical trial protocols. PATIEN ... Full text Link to item Cite

Clinical, Ethical, and Financial Considerations With Red Blood Cell Transfusion Support at the End of Life in Hematologic Malignancies.

Journal article Am J Hosp Palliat Care · June 22, 2026 Patients with advanced hematological malignancies often have red blood cell (RBC) transfusion needs at the end of life (EOL) to improve debilitating anemia-related symptoms. Given that patients with hematologic malignancies and their caregivers find that t ... Full text Link to item Cite
View All Scholarly Works

Recent Grants


Experience of Veterans with Myeloproliferative Neoplasms

ResearchPrincipal Investigator · Awarded by American Society of Clinical Oncology · 2025 - 2026

Exploring the impact of conditioning regimen selection on clinical outcomes and quality of life in

ResearchPI-Fellow · Awarded by American Society of Hematology · 2024 - 2026

View All Grants